Cargando…
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
The levels of serum beta 2 microglobulin, blood urea concentration, serum creatinine, haemoglobin and performance status have been measured in 476 patients in the Medical Research Council's 4th trial for myelomatosis. Levels of serum beta 2 microglobulin were also subsequently measured in 208 p...
Autores principales: | Cuzick, J., Cooper, E. H., MacLennan, I. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977159/ https://www.ncbi.nlm.nih.gov/pubmed/3893505 |
Ejemplares similares
-
Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
por: Norfolk, D., et al.
Publicado: (1980) -
Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
por: Child, J. A., et al.
Publicado: (1983) -
Urinary pseudouridine excretion in myelomatosis.
por: Sørensen, S. H., et al.
Publicado: (1985) -
Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.
por: MacLennan, I. C., et al.
Publicado: (1985) -
Anaemia in patients with myelomatosis.
por: Ting, W. C., et al.
Publicado: (1982)